Treating Mucus Hypersecretion in Colds and Influenza
This review covers the role of mucus hypersecretion in the pathogenesis of colds and flu and treatment options for mucus hypersecretion.
Respiratory Infections
Amoxicillin Not Effective for Pediatric Lower Respiratory Tract Infection
Amoxicillin unlikely to be clinically effective overall or in specified clinical subgroups in whom antibiotics are commonly prescribed.
Spotlight on Non-Ventilator-Associated Hospital-Acquired Pneumonia
Pneumonia prevention interventions such as proper oral care, head-of-bed elevation, and incentive spirometry, are not being provided to most patients outside the ICU, leading to greater than two-thirds of hospital-acquired pneumonia.
CDC Issues Alert About Respiratory Syncytial Virus Spread in Southern US
Agency is encouraging broader testing for RSV among patients presenting with acute respiratory illness who test negative for COVID-19
Gastrointestinal Infections May Be Associated With Weakened Lung Immunity
Investigators sought to better understand the immunologic mechanisms behind increased susceptibility to secondary respiratory infections.
Contactless Monitoring Program for Acute Respiratory Illnesses
Household transmission of noninfluenza respiratory viruses are thought to contribute significantly to transmission through the broader community.
Rehabilitation Trends in Patients With COVID-19 Requiring Invasive Ventilation
In patients with COVID-19 admitted to the ICU with a high acuity of illness and a prolonged period of mechanical ventilation, the time to start rehabilitation was often delayed because of the severity of an individual’s condition.
COVID-19 May Not Be Characterized by Cytokine Storm
The findings of a preliminary analysis suggest that COVID-19 may not be characterized by cytokine storm and therefore the benefit of anticytokine therapies remains to be determined.
Aspiration Pneumonia Mistaken for Community- Acquired Pneumonia
A patient with a history of achalasia presents to the emergency department with pneumonia that quickly leads to hypoxic respiratory failure.
Tocilizumab Reduces Need for Mechanical Ventilation in COVID-19 Pneumonia Trial
Patients treated with tocilizumab were 44% less likely to progress to mechanical ventilation or death compared with placebo.
- Loading...
Loading...
Next post in Infectious Diseases Information Center
Loading... 
Loading...